VYNE Therapeutics
VYNE
VYNE
32 hedge funds and large institutions have $16.1M invested in VYNE Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.66% less ownership
Funds ownership: 55.57% → 54.91% (-0.66%)
30% less capital invested
Capital invested by funds: $22.9M → $16.1M (-$6.8M)
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$751K | |
| 2 | +$737K | |
| 3 | +$120K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$59.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.9K |
Top Sellers
| 1 | -$692K | |
| 2 | -$345K | |
| 3 | -$265K | |
| 4 |
EAM
Exome Asset Management
New York
|
-$122K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$58.2K |